Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Compounded semaglutide injections remain legally available and widely prescribed for weight loss management across the United States. Unlike brand-name Ozempic or Wegovy, which face ongoing supply constraints, compounded versions manufactured by licensed 503A pharmacies offer patients an accessible alternative. PlexusDx specializes in personalized GLP-1 protocols that match individual metabolic profiles to optimize results.
Understanding Compounded Semaglutide Availability
Compounded semaglutide is produced by licensed 503A compounding pharmacies under strict pharmaceutical standards and state board oversight. These facilities prepare custom medications tailored to individual prescriptions, offering flexibility in dosing and delivery methods that mass-manufactured pharmaceuticals cannot. The FDA recognizes legitimate compounded medications as distinct from brand-name products, provided they meet specific quality and sterility requirements.
PlexusDx partners exclusively with licensed 503A compounding pharmacies to source semaglutide injections and other GLP-1 medications. All compounds are manufactured under current good manufacturing practice (cGMP) standards and delivered directly to patients across all 50 states. This model eliminates the inventory delays and regional shortages that have affected branded alternatives, ensuring consistent availability for patients seeking treatment.
How Compounded Semaglutide Differs From Brand-Name Options
Brand-name semaglutide products like Ozempic (diabetes) and Wegovy (weight loss) are manufactured by Novo Nordisk in large-scale facilities and distributed through traditional pharmaceutical channels. Compounded versions are prepared on-demand by 503A pharmacies, allowing for individualized concentrations and formulations based on prescriber recommendations. Both work through the same biological mechanism—activating GLP-1 receptors to reduce appetite and improve blood sugar regulation—but compounded preparations offer greater customization.
Compounded semaglutide typically costs less than brand-name alternatives and carries no insurance requirement or membership fees. PlexusDx's Compounded Semaglutide Injection starts at $149 per month across three commitment tiers, with pricing that remains flat regardless of dose adjustments. HSA and FSA accounts are accepted, making the medication accessible to a broader range of patients seeking affordable, personalized weight loss therapy.
Why Compounded Semaglutide Remains a Viable Treatment Path
Clinical evidence supporting semaglutide's efficacy for weight loss is robust and well-established. The STEP trials demonstrated that patients using semaglutide achieved weight reductions of 10-22% over 68 weeks, compared to 2-3% with placebo alone. These results, combined with improved cardiovascular outcomes and metabolic markers, have made semaglutide a cornerstone therapy for individuals with obesity or metabolic syndrome.
Compounded versions maintain the same active pharmaceutical ingredient and mechanism of action as brand-name products, allowing patients to achieve comparable clinical outcomes at a lower cost. PlexusDx offers both injection and oral semaglutide formulations, giving patients flexibility in administration preferences. For individuals who do not qualify for or cannot afford brand-name medications, compounded semaglutide represents a legitimate, legally available treatment option backed by the same scientific evidence.
Personalization With the Precision Peptide Genetic Test
Individual responses to semaglutide vary significantly based on genetic factors affecting GLP-1 signaling, appetite regulation, and metabolic pathways. PlexusDx's Precision Peptide Genetic Test analyzes key variants—including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—to predict how your body will respond to different GLP-1 therapies. This test maps 14 distinct metabolic pathways and provides insights into 150+ genetic determinants of treatment response.
The genetic test is offered as a $99 add-on after the first month of treatment, allowing patients to confirm that their chosen medication aligns with their peptide-pathway biology. Some patients with specific genetic profiles may respond better to tirzepatide, a dual GIP/GLP-1 agonist, while others achieve optimal results with semaglutide alone. Precision Peptide testing removes the guesswork from medication selection and helps PlexusDx patients achieve faster, more sustained weight loss and metabolic improvements.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide legal and safe?
Yes, compounded semaglutide is legal when manufactured by licensed 503A compounding pharmacies under strict FDA oversight and state pharmacy board regulations. PlexusDx sources exclusively from licensed facilities that maintain cGMP standards and undergo regular inspections.
How does compounded semaglutide compare in efficacy to Wegovy or Ozempic?
Compounded semaglutide contains the same active ingredient and activates GLP-1 receptors through the same biological pathway as Wegovy and Ozempic.
What does PlexusDx charge for compounded semaglutide?
PlexusDx offers Compounded Semaglutide Injection starting at $149 per month with flat pricing across three commitment tiers—your dose may need to go up, but your price won't. The medication is HSA/FSA eligible and available in all 50 states with no insurance requirement or membership fee.
Who should not use semaglutide?
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or severe pancreatitis. Pregnant patients should avoid it due to limited safety data. Side effects commonly include nausea, vomiting, and diarrhea, particularly during dose escalation.
How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?
The Precision Peptide Genetic Test identifies your genetic variants in GLP-1 and GIP receptor pathways, predicting which medication class—GLP-1 agonist like semaglutide, or dual GIP/GLP-1 agonist like tirzepatide—aligns better with your metabolism.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Does Ozempic Help You Lose Weight? A Comprehensive Overview
Can You Drink Alcohol on a GLP-1 Medication? What You Need to Know